Drugs / PSTB100
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07702279 | Jul 2026 → Jun 2027 expected | — | Prospect Therapeutics (Nanjing) Limited | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PSTB100 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07702279 ↗ |
| Route | Oral | “single oral doses of PSTB100 Tablets” NCT07702279 ↗ |